Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
Ann Surg. 2024 Jan 1;279(1):147-153. doi: 10.1097/SLA.0000000000006114. Epub 2023 Oct 6.
This study compared outcomes in patients with solid tumor treated for pericardial effusion with surgical drainage versus interventional radiology (IR) percutaneous drainage and compared incidence of paradoxical hemodynamic instability (PHI) between cohorts.
Patients with advanced-stage solid malignancies may develop large pericardial effusions requiring intervention. PHI is a fatal and underreported complication that occurs following pericardial effusion drainage.
Clinical characteristics and outcomes were compared between patients with solid tumors who underwent s urgical drainage or IR percutaneous drainage for pericardial effusion from 2010 to 2020.
Among 447 patients, 243 were treated with surgical drainage, of which 27 (11%) developed PHI, compared with 7 of 204 patients (3%) who were treated with IR percutaneous drainage ( P =0.002); overall incidence of PHI decreased during the study period. Rates of reintervention (30-day: 1% vs 4%; 90-day: 4% vs 6%, P =0.7) and mortality (30-day: 21% vs 17%, P =0.3; 90-day: 39% vs 37%, P =0.7) were not different between patients treated with surgical drainage and IR percutaneous drainage. For both interventions, OS was shorter among patients with PHI than among patients without PHI (surgical drainage, median [95% confidence interval] OS, 0.89 mo [0.33-2.1] vs 6.5 mo [5.0-8.9], P <0.001; IR percutaneous drainage, 3.7 mo [0.23-6.8] vs 5.0 mo [4.0-8.1], P =0.044).
With a coordinated multidisciplinary approach focusing on prompt clinical and echocardiographic evaluation, triage with bias toward IR percutaneous drainage than surgical drainage and postintervention intensive care resulted in lower incidence of PHI and improved outcomes.
本研究比较了接受手术引流与介入放射学(IR)经皮引流治疗心包积液的实体瘤患者的结局,并比较了两组患者发生矛盾性血流动力学不稳定(PHI)的发生率。
晚期实体恶性肿瘤患者可能会出现需要干预的大量心包积液。PHI 是一种致命且报道不足的并发症,发生在心包积液引流后。
比较了 2010 年至 2020 年间接受手术引流或 IR 经皮引流治疗心包积液的实体瘤患者的临床特征和结局。
在 447 名患者中,有 243 名接受了手术引流,其中 27 名(11%)发生了 PHI,而 204 名接受 IR 经皮引流的患者中只有 7 名(3%)发生了 PHI(P=0.002);在研究期间,PHI 的总发生率有所下降。再干预率(30 天:1%比 4%;90 天:4%比 6%,P=0.7)和死亡率(30 天:21%比 17%,P=0.3;90 天:39%比 37%,P=0.7)在接受手术引流和 IR 经皮引流的患者之间没有差异。对于两种干预措施,发生 PHI 的患者的 OS 短于未发生 PHI 的患者(手术引流,中位[95%置信区间]OS,0.89 个月[0.33-2.1]比 6.5 个月[5.0-8.9],P<0.001;IR 经皮引流,3.7 个月[0.23-6.8]比 5.0 个月[4.0-8.1],P=0.044)。
通过采用协调的多学科方法,重点进行及时的临床和超声心动图评估,对 IR 经皮引流的倾向进行分诊,而不是手术引流,并在干预后进行强化护理,可降低 PHI 的发生率并改善结局。